Form 8-K - Current report:
SEC Accession No. 0001185185-18-000161
Filing Date
2018-02-02
Accepted
2018-02-02 16:49:29
Documents
7
Period of Report
2018-01-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biostar8k020218.htm 8-K 22304
2 EX-16.1 ex16-1.htm EX-16.1 6091
3 image3.jpg GRAPHIC 12986
4 image00004.jpg GRAPHIC 3519
5 image00005.jpg GRAPHIC 2617
6 image00006.jpg GRAPHIC 3407
7 image00007.jpg GRAPHIC 2342
  Complete submission text file 0001185185-18-000161.txt   64389
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34708 | Film No.: 18571435
SIC: 2834 Pharmaceutical Preparations